Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Evaluating sleep changes in patients with inflammatory bowel diseases.

Official title: Evaluation of Sleep Changes as Early Markers of Relapse in Patients With Inflammatory Bowel Diseases (IBD).

Run by Hospices Civils de Lyon · NCT05835973 · Data updated 2026-11-12

This study is trying to see if better sleep can help people with inflammatory bowel diseases, like Crohn's and ulcerative colitis, avoid flare-ups.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment216 (estimated)
SponsorHospices Civils de Lyon
Academic / other
Locations4 sites (Clermont-Ferrand and 3 other locations)
StatusRecruiting
StartedApril 8, 2025
Main results expectedApril 8, 2028
Study endsJune 8, 2028
Registry record updatedNovember 21, 2025
Trial IDNCT05835973 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 65 with a diagnosis of inflammatory bowel disease in remission for at least three months.

Probably not a fit

Patients with active complications, extensive bowel resections, or pre-existing sleep disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess the relationship between sleep quality and the risk of flare-ups in patients with inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis. Patients who have been in remission for at least three months will undergo evaluations of their IBD symptoms and sleep patterns over the course of one year. The study will utilize various methods including actigraphy, questionnaires, and clinical assessments to monitor changes in sleep efficacy and its potential predictive value for IBD flare-ups.

Why it matters

Potential benefit: If successful, this study could help identify patients at risk of flare-ups based on sleep patterns, leading to timely interventions.

How similar studies have gone: While the relationship between sleep and IBD is being explored, this specific approach to predicting flare-ups through sleep assessment is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient over 18 and under 65 years of age.
* Patient with Inflammatory Bowel Disease diagnosed for at least 3 months.
* Patient in remission, for at least 3 months:

  1. clinical remission: Harvey-Bradshaw score (HBI) \< 5 for CD and a Mayo score \< 3 for UC
  2. and biological remission: absence of objective inflammation defined by CRP \< 5 mg/L and/or fecal calprotectin \< 250 µg/g.
* Patient must sign informed consent form to participate to the study.
* Patient affiliated to or benefiting from a social security plan.

Exclusion Criteria:

* Patient with complications (obstructive symptoms, fistulas or intra-abdominal abscesses in the previous three months).
* Patient with extensive bowel resection (\> 40 cm of small bowel).
* Patient with an ileostomy or colostomy.
* Patient diagnosed with sleep disorders.
* Patient without legal capacity to consent.
* Pregnant, parturient or nursing women.
* Persons deprived of liberty by judicial or administrative decision.
* Persons under psychiatric care.
* Persons admitted to a health or social institution for purposes other than research.
* Persons of full age who are subject to a legal protection measure (guardianship, curators).

Where it's running

  • Lyon Sud hospital
    Pierre-Bénite, France
    Recruiting
  • CHU Clermont-Ferrand, Hôpital d'Estaing
    Clermont-Ferrand, France
    Not yet recruiting
  • CHU Grenoble Hôpital Michallon-Site Nord
    Grenoble, France
    Not yet recruiting
  • CHU Saint Etienne
    Saint-Etienne, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.